Compounds > 17-(3-pyridyl)androsta-5,16-dien-3-one
Page last updated: 2024-09-05

17-(3-pyridyl)androsta-5,16-dien-3-one and 3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene

17-(3-pyridyl)androsta-5,16-dien-3-one has been researched along with 3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene in 1 studies

Compound Research Comparison

Studies
(17-(3-pyridyl)androsta-5,16-dien-3-one)		Trials
(17-(3-pyridyl)androsta-5,16-dien-3-one)		Recent Studies (post-2010)
(17-(3-pyridyl)androsta-5,16-dien-3-one)		Studies
(3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene)		Trials
(3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene)		Recent Studies (post-2010) (3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene)
80650244

Protein Interaction Comparison

ProteinTaxonomy17-(3-pyridyl)androsta-5,16-dien-3-one (IC50)3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene (IC50)
Steroid 17-alpha-hydroxylase/17,20 lyaseHomo sapiens (human)0.253
Steroid 21-hydroxylaseHomo sapiens (human)0.1626
Androgen receptorHomo sapiens (human)1.108

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aubé, J; Fehl, C; Li, K; Scott, EE; Vogt, CD; Yadav, R1

Other Studies

1 other study(ies) available for 17-(3-pyridyl)androsta-5,16-dien-3-one and 3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene

ArticleYear
Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2.
    Journal of medicinal chemistry, 2018, 06-14, Volume: 61, Issue:11

    Topics: Androstenes; Catalytic Domain; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Humans; Molecular Docking Simulation; Steroid 17-alpha-Hydroxylase; Steroid 21-Hydroxylase

2018